BioTech and Pharma
Pharmaceutical and BioTech Network Segmentation with Manufacturing System Microsegmentation
Pharmaceutical and biotech manufacturing, have complex cyber-physical environments where drug discovery, clinical trials, and production systems interconnect. Elisity's identity-based microsegmentation empowers pharmaceutical enterprises to secure their manufacturing operations, protect intellectual property, and maintain regulatory compliance while achieving FDA cybersecurity guidelines and IEC 62443 standards without disrupting critical production processes.
Challenges
Pharmaceutical and biotech organizations with multiple manufacturing sites, R&D facilities, and global supply chains face unprecedented security challenges as operational technology (OT) systems connect to enterprise networks. Traditional network segmentation approaches cannot protect these highly regulated environments without risking production downtime or compromising Good Manufacturing Practices (GMP).



Customer Spotlight
“Elisity’s deployment at GSK is nothing short of revolutionary, making every other solution pale in comparison.”
— Michael Elmore, CISO, GSK
Network Segmentation Without Compromise
The Numbers
Main Line Health deploys Elisity microsegmentation enterprise-wide across their Cisco infrastructure with Armis integration, providing comprehensive protection at every facility with network presence.
270+
Actively Enforced Policies
302,000
Devices Protected by Microsegmentation Policies
110
Gloabl Sites - Manufacturing, Labs, Orrices
3
As GSK rides the wave of global expansion, it successfully initiates three new Elisity-powered sites every week.
Challenge
Expanded Manufacturing Attack Surface
The convergence of IT and OT in pharmaceutical manufacturing has created new attack vectors that cybercriminals exploit to steal intellectual property, disrupt production, or compromise drug safety. With thousands of connected devices spanning multiple sites globally, pharmaceutical companies struggle to maintain visibility and control while meeting stringent FDA requirements.

Elisity Solution
Comprehensive Manufacturing Visibility
Elisity IdentityGraph™ transforms your switches into intelligent sensors that automatically discover and classify all connected assets—including bioreactors, SCADA systems, laboratory equipment, and building management systems—providing complete visibility across your entire pharmaceutical manufacturing environment without disrupting validated processes.
Challenge
Legacy OT System Vulnerabilities
Manufacturing equipment and process control systems often run proprietary software with 10-15 year lifecycles, making them impossible to patch without lengthy revalidation. These systems represent critical infrastructure for drug production but remain unprotected by conventional security tools.

Elisity Solution
FDA-Compliant Segmentation
Implement the zone and conduit architecture required by FDA's OT cybersecurity guidance and IEC 62443 standards through identity-based policy groups that segment your manufacturing environment without complex VLAN configurations or network changes. Our solution ensures compliance with 21 CFR Part 11 and cGMP requirements.
Challenge
Regulatory Compliance Complexity
Meeting FDA cybersecurity guidelines, IEC 62443 requirements, and maintaining GMP compliance while implementing security controls creates operational challenges. Traditional approaches require extensive validation documentation and risk disrupting qualified systems.

Elisity Solution
Zero-Disruption Deployment
Deploy pharmaceutical microsegmentation using your existing network infrastructure without new hardware, agents on validated systems, or production downtime—maintaining continuous manufacturing operations critical to drug supply chains.

Supply Chain and IP Protection
Pharmaceutical companies cannot tolerate security implementations that risk intellectual property theft or supply chain disruption, creating resistance to implementing proper controls while maintaining global operations across contract manufacturers and research partners.

Elisity Solution
Phased Security Implementation
Roll out policies using Elisity's Simulation Mode to analyze impact on manufacturing processes, identify potential issues, and refine controls before enforcement, safeguarding your operations while protecting valuable research and production data.
Resources
Transform Your Pharma Network Security in Weeks, Not YearsElisity Microsegmentation: Accelerate Zero Trust Security in Weeks, Not Years
See how GSK reduced microsegmentation costs by 75% while protecting 275 global sites from ransomware and compliance violations. Discover Elisity's identity-based architecture—a leap forward that eliminates the need for new hardware, agents, VLANs, or complex ACLs.

Get Started
Stop East-West Attacks, Microsegment Your Networks
Pharmaceutical Manufacturing & Biotech Security FAQ
See how Elisity helps pharmaceutical and biotech companies secure manufacturing systems while maintaining compliance and operational continuity. These FAQs answer the most common questions from security and manufacturing teams.
Elisity's identity-based microsegmentation secures each system at the network level without requiring any software on validated equipment. By limiting communications to only what's necessary for manufacturing processes, it protects critical OT systems from threats.
Yes, Elisity automatically discovers and classifies all connected manufacturing assets, then enforces zone-based segmentation policies that meet FDA OT guidance and IEC 62443 requirements. It provides the documentation and audit trails needed for regulatory compliance.
Absolutely. Elisity's agentless solution uses your existing network infrastructure, allowing you to deploy security policies without any changes to validated systems. You can simulate policies before enforcement to ensure no impact on GMP processes.
Elisity consolidates OT security into one platform that understands manufacturing contexts. This unified approach means fewer consoles to manage and consistent enforcement across all sites, freeing your team from complex firewall and VLAN management.
Resources

Zero Trust Assessment for Pharmaceutical and BioTech Companies: A Practical Implementation Guide

FDA's New OT Cybersecurity Guidance: A Critical Roadmap for Pharmaceutical and Biotech Manufacturing Security

List of Must-See Talks at Black Hat 2025 in Las Vegas
Ready to Prevent Lateral Movement? Secure Your Network in Weeks, Not Years
Don't wait for attackers to exploit your east-west traffic security policy gaps. Implement Elisity's identity-based microsegmentation without agents, hardware, or network changes. Discover 99% of all users, workloads, and devices in one day, create dynamic least privilege policies, and prevent lateral movement—all while leveraging your existing infrastructure. Schedule your personalized demo today.
Schedule Time With Us